SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

18 May 2023 Evaluate
The sales surged to Rs. 25793.00 millions, up 30.48% for the March 2023 quarter as against Rs. 19768.00 millions during the corresponding quarter previous year.Profit for the quarter ended March 2023 rises by 98.74% to Rs. 4907.00  millions from Rs. 2469.00 millions.Operating Profit saw a handsome growth to 10237.00 millions from 5113.00 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 25793.00 19768.00 30.48 87316.00 78369.00 11.42 87316.00 78369.00 11.42
Other Income 2512.00 537.00 367.78 5484.00 1787.00 206.88 5484.00 1787.00 206.88
PBIDT 10237.00 5113.00 100.22 30028.00 20968.00 43.21 30028.00 20968.00 43.21
Interest 850.00 420.00 102.38 2782.00 1349.00 106.23 2782.00 1349.00 106.23
PBDT 7349.00 4693.00 56.59 25208.00 16426.00 53.46 25208.00 16426.00 53.46
Depreciation 1199.00 1228.00 -2.36 4886.00 4787.00 2.07 4886.00 4787.00 2.07
PBT 6150.00 3465.00 77.49 20322.00 11639.00 74.60 20322.00 11639.00 74.60
TAX 1243.00 996.00 24.80 5030.00 3060.00 64.38 5030.00 3060.00 64.38
Deferred Tax -53.00 217.00 -124.42 412.00 458.00 -10.04 412.00 458.00 -10.04
PAT 4907.00 2469.00 98.74 15292.00 8579.00 78.25 15292.00 8579.00 78.25
Equity 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 39.69 25.87 53.45 34.39 26.76 28.53 34.39 26.76 28.53

Zydus Lifesciences Share Price

942.40 -0.15 (-0.02%)
20-Apr-2026 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.55
Dr. Reddys Lab 1235.85
Cipla 1236.15
Zydus Lifesciences 942.40
Lupin 2334.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×